Courtney L Sutphen
Overview
Explore the profile of Courtney L Sutphen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lockhart S, Sutphen C, Tanley J, Gonzalez-Ortiz F, Kac P, Habes M, et al.
medRxiv
. 2025 Feb;
PMID: 39990571
Introduction: Little is known about how Alzheimer's disease (AD) plasma biomarkers relate to cerebral small vessel disease (cSVD) neuroimaging biomarkers. Methods: The study involved 251 Wake Forest Multi-Ethnic Study of...
2.
Rudolph M, Sutphen C, Register T, Lockhart S, Rundle M, Hughes T, et al.
medRxiv
. 2025 Feb;
PMID: 39974029
Introduction: Studies suggest excellent performance of plasma p-tau217 for detecting amyloid pathology, though studies in more diverse populations are needed to validate previously determined cutpoints. Methods: Plasma p-tau217 utility for...
3.
Vermunt L, Sutphen C, Dicks E, de Leeuw D, Allegri R, Berman S, et al.
Brain Commun
. 2024 Oct;
6(5):fcae357.
PMID: 39440304
The grey matter of the brain develops and declines in coordinated patterns during the lifespan. Such covariation patterns of grey matter structure can be quantified as grey matter networks, which...
4.
Rudolph M, Sutphen C, Register T, Whitlow C, Solingapuram Sai K, Hughes T, et al.
Alzheimers Dement
. 2024 May;
20(6):4159-4173.
PMID: 38747525
Introduction: We evaluated associations between plasma and neuroimaging-derived biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities. Methods: We examined plasma biomarkers (neurofilament light chain, glial...
5.
Shively C, Frye B, Negrey J, Johnson C, Sutphen C, Molina A, et al.
Neurosci Biobehav Rev
. 2023 Jul;
152:105320.
PMID: 37453725
Social disadvantage and diet composition independently impact myriad dimensions of health. They are closely entwined, as social disadvantage often yields poor diet quality, and may interact to fuel differential health...
6.
Eisenstein S, Boodram R, Sutphen C, Lugar H, Gordon B, Marshall B, et al.
Front Neurosci
. 2022 May;
16:795317.
PMID: 35495027
Wolfram syndrome is a rare disease caused by pathogenic variants in the gene with progressive neurodegeneration. As an easily accessible biomarker of progression of neurodegeneration has not yet been found,...
7.
Butt O, Long J, Henson R, Herries E, Sutphen C, Fagan A, et al.
Neurobiol Aging
. 2021 Mar;
102:64-72.
PMID: 33765432
Cerebrospinal fluid (CSF) synaptosomal-associated protein 25 (SNAP-25) and neurogranin (Ng) are recently described biomarkers for pre- and postsynaptic integrity known to be elevated in symptomatic Alzheimer disease (AD). Their relationship...
8.
Wang Q, Wang Y, Liu J, Sutphen C, Cruchaga C, Blazey T, et al.
Neuroimage Clin
. 2019 Mar;
22:101767.
PMID: 30901713
Interest in understanding the roles of white matter (WM) inflammation and damage in the pathophysiology of Alzheimer disease (AD) has been growing significantly in recent years. However, in vivo magnetic...
9.
Sutphen C, McCue L, Herries E, Xiong C, Ladenson J, Holtzman D, et al.
Alzheimers Dement
. 2018 Mar;
14(7):869-879.
PMID: 29580670
Introduction: Individuals in early stages of Alzheimer's disease are a targeted population for secondary prevention trials aimed at preserving normal cognition. Understanding within-person biomarker(s) change over time is critical for...
10.
Schindler S, Sutphen C, Teunissen C, McCue L, Morris J, Holtzman D, et al.
Alzheimers Dement
. 2017 Jul;
14(1):62-70.
PMID: 28710906
Introduction: The best-established cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease are levels of amyloid β 42 (Aβ42), total tau (tau), and phosphorylated tau 181 (ptau). We examined whether a widely...